Coronavirus information

Visitor restrictions, information for patients and more.

View coronavirus information

FOI 0491 2019/20 Juvenile Ideopathic Arthritis

Home > FOI Requests > Patient Data > FOI 0491 2019/20 Juvenile Ideopathic Arthritis

December 16, 2019

Last updated: December 16, 2019

Freedom of Information Request: 0491 2019/20

I would like to understand how patients with juvenile ideopathic arthritis are being treated. So, in the last 6 months (1/05/19-1/11/19), how many patient(s) with juvenile ideopathic arthritis have been treated with:

Drug Number of Patients
Humira (adalimumab) 0
Amgevita (adalimumab) 0
Imraldi (adalimumab) 0
Hyrimoz (adalimumab) 0
Hulio (adalimumab) 0
Tocilizumab 0
Abatacept 0
Enbrel (etanercept) 0
Erelzi (etanercept) 0
Benepali (etanercept) 0
Golimumab 0
Remicade (infliximab) 0
Remsima (infliximab) 0
Inflectra (infliximab) 0
Flixabi (infliximab) 0
Canakinumab 0
Anakinra 0

 

 

Thinking of going to Accident and Emergency but not sure if you need to? Try our handy symptom checker.

Try ask A&E

We're improving the accessibility of our websites. If you can't access any content or if you would like to request information in another format, please view our accessibility statement.